|
Cayman Chemical 1180 East Ellsworth Road Ann Arbor, Michigan 48108 USA
|
2
|
Resverlogix Corp.
|
Jan 15, 2017 04:53PM
|
|
$2.37 up to $2.69 ,,,,,,,swoon!
|
2
|
Resverlogix Corp.
|
Jun 18, 2018 03:24PM
|
|
10 Year Anniversary for Resverlogix's Newco !!
|
2
|
Zenith Epigenetics
|
Jan 19, 2023 07:21AM
|
|
52 week high is showing as $2.47 !!
|
3
|
Resverlogix Corp.
|
Jun 18, 2018 03:30PM
|
|
6 months to August,,it was 12 just a short time ago!!!
|
2
|
Resverlogix Corp.
|
Jan 31, 2017 08:18PM
|
|
A very welcomed relief rally for all!!
|
5
|
Resverlogix Corp.
|
Jun 18, 2018 04:02PM
|
|
Alzheimers and Epigenetics!
|
1
|
Resverlogix Corp.
|
Jan 24, 2019 11:10AM
|
|
Another IPO that shocks!
|
4
|
Zenith Epigenetics
|
Jan 13, 2021 02:17PM
|
|
Approval of First ‘Epigenetic’ Drug for a Solid Tumor: January 31, 2020
|
2
|
Resverlogix Corp.
|
Aug 18, 2022 08:14PM
|
|
AZ gets approval for Farxiga.
|
2
|
Resverlogix Corp.
|
Oct 21, 2019 07:18AM
|
|
Bioasis Announces Allowance of Patent Application in Japan Relating to xB³ Platform Technology.
|
2
|
BIOASIS TECHNOLOGIES INC
|
Sep 10, 2019 08:24PM
|
|
Bioasis Vs Annexon Inc.
|
|
BIOASIS TECHNOLOGIES INC
|
Sep 15, 2022 07:47AM
|
|
Bioasis will present at the 25th Annual BIO International Convention, to be held June 4-7, 2018 at the Boston Convention & Exhibition Center.
|
1
|
BIOASIS TECHNOLOGIES INC
|
May 26, 2018 09:49AM
|
|
Biogen looks to FDA for approval of early Alzheimers drug.
|
5
|
Resverlogix Corp.
|
Oct 22, 2019 07:16AM
|
|
Can't access the Zacks reports anymore?
|
|
BIOASIS TECHNOLOGIES INC
|
Apr 06, 2021 05:01PM
|
|
Canada RVX TSX/CA Resverlogix Corp. 0.055 CAD -0.005 (-8.33%).
|
1
|
Resverlogix Corp.
|
Mar 04, 2024 10:07AM
|
|
Canadian funds slow to invest in thriving biotech industry.
|
5
|
Resverlogix Corp.
|
Dec 03, 2020 06:40PM
|
|
Canadian Insider Activity for Resverlogix.
|
6
|
Resverlogix Corp.
|
Jan 10, 2024 06:40AM
|
|
Canadian Investment Regulatory Organization Trading Halt - BTI 2 hours ago
|
1
|
BIOASIS TECHNOLOGIES INC
|
Mar 21, 2024 09:28AM
|
|
Celgene inks $1B deal for a preclinical epigenetic blood cancer drug from Canada.
|
3
|
Zenith Epigenetics
|
Jan 29, 2019 07:42PM
|
